<DOC>
	<DOC>NCT01370304</DOC>
	<brief_summary>The purpose of this study is to treat participants with a diagnosis of depressive disorder to assess the efficacy of repetitive Transcranial Magnetic Stimulation (rTMS) and venlafaxine in the treatment of depressive disorders compared venlafaxine only (the optimal medication) and to rTMS only. fMRI will be performed to determine if treatment response is related to changes in fMRI, and use it to investigate the respondence to the treatments.</brief_summary>
	<brief_title>Repetitive Transcranial Magnetic Stimulation Compared or Associated With Venlafaxine for Depressive Disorder</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Venlafaxine Hydrochloride</mesh_term>
	<criteria>18 years and older Clinical diagnosis of major depressive disorder (DSMIV) HDRS17 items &gt; 20 Failure of one antidepressant treatment (efficacious doses for 6 weeks at least) Psychotic features Failure of one previous venlafaxine treatment Addiction comorbidity or schizophrenia comorbidity Involuntary hospitalization Seizures history Pregnancy or breastfeeding Somatic comorbidity able to impact on cognitive functions</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>repetitive Transcranial Magnetic Stimulation (rTMS)</keyword>
	<keyword>Depression</keyword>
	<keyword>Venlafaxine</keyword>
	<keyword>fMRI</keyword>
</DOC>